Upregulations of P2X3 and ASIC3 involve in hyperalgesia induced by cisplatin administration in rats

Pain

Volumn 149, Issue 2, 2010, Pages 393-405

  Hori, Kiyomi ^a,b   Ozaki, Noriyuki ^c   Suzuki, Shigeyuki ^a   Sugiura, Yasuo ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

^c KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

ASIC3; Cisplatin; Hyperalgesia; P2X3; TRPV1; TRPV2

Indexed keywords

ACID SENSING ION CHANNEL; ACID SENSING ION CHANNEL 3; CISPLATIN; ION CHANNEL; PURINERGIC P2X3 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 2;

ALLODYNIA; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; GASTROCNEMIUS MUSCLE; GRIP STRENGTH; HYPERALGESIA; MALE; MOTOR COORDINATION; MUSCLE INNERVATION; MUSCLE SPINDLE AFFERENT NERVE; NOCICEPTION; NONHUMAN; PERIPHERAL NEUROPATHY; PRICK TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; RECEPTOR UPREGULATION; ROTAROD TEST; SENSORY NERVE CELL; SPINAL GANGLION; TREATMENT DURATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; DISEASE MODELS, ANIMAL; GANGLIA, SPINAL; HYPERALGESIA; MALE; MUSCLE, SKELETAL; NERVE TISSUE PROTEINS; NOCICEPTORS; PAIN MEASUREMENT; PERIPHERAL NERVES; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2; SENSORY RECEPTOR CELLS; SKIN; SODIUM CHANNELS; TRPV CATION CHANNELS; UP-REGULATION;

EID: 77951767398     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2010.03.005     Document Type: Article

References (58)

1. Ahluwalia J., Rang H., and Nagy I. The putative role of vanilloid receptor-like protein-1 in mediating high threshold noxious heat-sensitivity in rat cultured primary sensory neurons. Eur J Neurosci 16 (2002) 1483-1489
2. Aley K.O., and Levine J.D. Different peripheral mechanisms mediate enhanced nociception in metabolic/toxic and traumatic painful peripheral neuropathies in the rat. Neuroscience 111 (2002) 389-397
3. Authier N., Fialip J., Eschalier A., and Coudore F. Assessment of allodynia and hyperalgesia after cisplatin administration to rats. Neurosci Lett 291 (2000) 73-76
4. Authier N., Gillet J.P., Fialip J., Eschalier A., and Coudore F. An animal model of nociceptive peripheral neuropathy following repeated cisplatin injections. Exp Neurol 182 (2003) 12-20
5. Begon S., Pickering G., Eschalier A., and Dubray C. Magnesium and MK-801 have a similar effect in two experimental models of neuropathic pain. Brain Res 887 (2000) 436-439
6. Bennett G.J., and Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33 (1988) 87-107
7. Blackburn-Munro G., Bomholt S.F., and Erichsen H.K. Behavioural effects of the novel AMPA/GluR5 selective receptor antagonist NS1209 after systemic administration in animal models of experimental pain. Neuropharmacology 47 (2004) 351-362
8. Bolcskei K., Helyes Z., Szabo A., Sandor K., Elekes K., Nemeth J., Almasi R., Pinter E., Petho G., and Szolcsanyi J. Investigation of the role of TRPV1 receptors in acute and chronic nociceptive processes using gene-deficient mice. Pain 117 (2005) 368-376
9. Boyle F.M., Wheeler H.R., and Shenfield G.M. Amelioration of experimental cisplatin and paclitaxel neuropathy with glutamate. J Neurooncol 41 (1999) 107-116
10. Burnstock G. P2X receptors in sensory neurones. Br J Anaesth 84 (2000) 476-488
11. Caterina M.J., Rosen T.A., Tominaga M., Brake A.J., and Julius D. A capsaicin-receptor homologue with a high threshold for noxious heat. Nature 398 (1999) 436-441
12. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., and Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389 (1997) 816-824
13. Chen Y., Li G.W., Wang C., Gu Y., and Huang L.Y. Mechanisms underlying enhanced P2X receptor-mediated responses in the neuropathic pain state. Pain 119 (2005) 38-48
14. Cook S.P., Vulchanova L., Hargreaves K.M., Elde R., and McCleskey E.W. Distinct ATP receptors on pain-sensing and stretch-sensing neurons. Nature 387 (1997) 505-508
15. De Koning P., Neijt J.P., Jennekens F.G., and Gispen W.H. Evaluation of cis-diamminedichloroplatinum (II) (cisplatin) neurotoxicity in rats. Toxicol Appl Pharmacol 89 (1987) 81-87
16. Diochot S., Salinas M., Baron A., Escoubas P., and Lazdunski M. Peptides inhibitors of acid-sensing ion channels. Toxicon 49 (2007) 271-284
17. Dunham N.W., and Miya T.S. A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc Am Pharm Assoc (Baltim) 46 (1957) 208-209
18. Ferreira J., Santos A.R., and Calixto J.B. Antinociception produced by systemic, spinal and supraspinal administration of amiloride in mice. Life Sci 65 (1999) 1059-1066
19. Fukuoka T., Tokunaga A., Tachibana T., Dai Y., Yamanaka H., and Noguchi K. VR1, but not P2X(3), increases in the spared L4 DRG in rats with L5 spinal nerve ligation. Pain 99 (2002) 111-120
20. Godecke S., Stumpe T., Schiller H., Schnittler H.J., and Schrader J. Do rat cardiac myocytes release ATP on contraction?. Am J Physiol Cell Physiol 289 (2005) C609-C616
21. Greffrath W., Binzen U., Schwarz S.T., Saaler-Reinhardt S., and Treede R.D. Co-expression of heat sensitive vanilloid receptor subtypes in rat dorsal root ganglion neurons. Neuroreport 14 (2003) 2251-2255
22. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
23. Hoheisel U., Reinohl J., Unger T., and Mense S. Acidic pH and capsaicin activate mechanosensitive group IV muscle receptors in the rat. Pain 110 (2004) 149-157
24. Hudson L.J., Bevan S., Wotherspoon G., Gentry C., Fox A., and Winter J. VR1 protein expression increases in undamaged DRG neurons after partial nerve injury. Eur J Neurosci 13 (2001) 2105-2114
25. Hwang S.W., Cho H., Kwak J., Lee S.Y., Kang C.J., Jung J., Cho S., Min K.H., Suh Y.G., Kim D., and Oh U. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc Natl Acad Sci USA 97 (2000) 6155-6160
26. Iwata Y., Katanosaka Y., Arai Y., Komamura K., Miyatake K., and Shigekawa M. A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor-regulated channel. J Cell Biol 161 (2003) 957-967
27. Jamieson E.R., and Lippard S.J. Structure, recognition, and processing of cisplatin-DNA adducts. Chem Rev 99 (1999) 2467-2498
28. 2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc Natl Acad Sci USA 99 (2002) 17179-17184
29. Julius D., and Basbaum A.I. Molecular mechanisms of nociception. Nature 413 (2001) 203-210
30. Kehl L.J., Trempe T.M., and Hargreaves K.M. A new animal model for assessing mechanisms and management of muscle hyperalgesia. Pain 85 (2000) 333-343
31. Kniffki K.D., Mense S., and Schmidt R.F. Responses of group IV afferent units from skeletal muscle to stretch, contraction and chemical stimulation. Exp Brain Res 31 (1978) 511-522
32. Krarup-Hansen A., Fugleholm K., Helweg-Larsen S., Hauge E.N., Schmalbruch H., Trojaborg W., and Krarup C. Examination of distal involvement in cisplatin-induced neuropathy in man. An electrophysiological and histological study with particular reference to touch receptor function. Brain 116 (1993) 1017-1041
33. Krishtal O. The ASICs: signaling molecules? Modulators?. Trends Neurosci 26 (2003) 477-483
34. Li J., King N.C., and Sinoway L.I. Interstitial ATP and norepinephrine concentrations in active muscle. Circulation 111 (2005) 2748-2751
35. 2/3-related antinociception in rat models of inflammatory and chemogenic pain but not neuropathic pain. Br J Pharmacol 146 (2005) 180-188
36. Mense S., and Skeppar P. Discharge behaviour of feline gamma-motoneurones following induction of an artificial myositis. Pain 46 (1991) 201-210
37. Molliver D.C., Immke D.C., Fierro L., Pare M., Rice F.L., and McCleskey E.W. ASIC3, an acid-sensing ion channel, is expressed in metaboreceptive sensory neurons. Mol Pain 1 (2005) 35
38. Muraki K., Iwata Y., Katanosaka Y., Ito T., Ohya S., Shigekawa M., and Imaizumi Y. TRPV2 is a component of osmotically sensitive cation channels in murine aortic myocytes. Circ Res 93 (2003) 829-838
39. 3 receptors and peripheral pain mechanisms. J Physiol 554 (2004) 301-308
40. Omori M., Yokoyama M., Matsuoka Y., Kobayashi H., Mizobuchi S., Itano Y., Morita K., and Ichikawa H. Effects of selective spinal nerve ligation on acetic acid-induced nociceptive responses and ASIC3 immunoreactivity in the rat dorsal root ganglion. Brain Res 1219 (2008) 26-31
41. O'Neil R.G., and Heller S. The mechanosensitive nature of TRPV channels. Pflugers Arch 451 (2005) 193-203
42. Price M.P., McIlwrath S.L., Xie J., Cheng C., Qiao J., Tarr D.E., Sluka K.A., Brennan T.J., Lewin G.R., and Welsh M.J. The DRASIC cation channel contributes to the detection of cutaneous touch and acid stimuli in mice. Neuron 32 (2001) 1071-1083
43. Rashid M.H., Inoue M., Kondo S., Kawashima T., Bakoshi S., and Ueda H. Novel expression of vanilloid receptor 1 on capsaicin-insensitive fibers accounts for the analgesic effect of capsaicin cream in neuropathic pain. J Pharmacol Exp Ther 304 (2003) 940-948
44. Reinohl J., Hoheisel U., Unger T., and Mense S. Adenosine triphosphate as a stimulant for nociceptive and non-nociceptive muscle group IV receptors in the rat. Neurosci Lett 338 (2003) 25-28
45. Rustay N.R., Wahlsten D., and Crabbe J.C. Influence of task parameters on rotarod performance and sensitivity to ethanol in mice. Behav Brain Res 141 (2003) 237-249
46. Sharp C.J., Reeve A.J., Collins S.D., Martindale J.C., Summerfield S.G., Sargent B.S., Bate S.T., and Chessell I.P. Investigation into the role of P2X(3)/P2X(2/3) receptors in neuropathic pain following chronic constriction injury in the rat: an electrophysiological study. Br J Pharmacol 148 (2006) 845-852
47. Shimosato G., Amaya F., Ueda M., Tanaka Y., Decosterd I., and Tanaka M. Peripheral inflammation induces up-regulation of TRPV2 expression in rat DRG. Pain 119 (2005) 225-232
48. Shinoda M., Ozaki N., and Sugiura Y. Involvement of ATP and its receptors on nociception in rat model of masseter muscle pain. Pain 134 (2008) 148-157
49. Sluka K.A., Radhakrishnan R., Benson C.J., Eshcol J.O., Price M.P., Babinski K., Audette K.M., Yeomans D.C., and Wilson S.P. ASIC3 in muscle mediates mechanical, but not heat, hyperalgesia associated with muscle inflammation. Pain 129 (2007) 102-112
50. Smart D., Gunthorpe M.J., Jerman J.C., Nasir S., Gray J., Muir A.I., Chambers J.K., Randall A.D., and Davis J.B. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol 129 (2000) 227-230
51. Ta L.E., Espeset L., Podratz J., and Windebank A.J. Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding. Neurotoxicology 27 (2006) 992-1002
52. Takahashi K., Taguchi T., Itoh K., Okada K., Kawakita K., and Mizumura K. Influence of surface anesthesia on the pressure pain threshold measured with different-sized probes. Somatosens Mot Res 22 (2005) 299-305
53. Tal M., and Bennett G.J. Neuropathic pain sensations are differentially sensitive to dextrorphan. Neuroreport 5 (1994) 1438-1440
54. Tredici G., Braga M., Nicolini G., Miloso M., Marmiroli P., Schenone A., Nobbio L., Frattola L., and Cavaletti G. Effect of recombinant human nerve growth factor on cisplatin neurotoxicity in rats. Exp Neurol 159 (1999) 551-558
55. Wang D., and Lippard S.J. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 4 (2005) 307-320
56. Wood J.N. Ion channels in analgesia research. Handb Exp Pharmacol 177 (2007) 329-358
57. Yao X., Panichpisal K., Kurtzman N., and Nugent K. Cisplatin nephrotoxicity: a review. Am J Med Sci 334 (2007) 115-124
58. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110